Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2008 07:00 ET | Source: Eurand N.V.

Eurand Reports Recent Developments and Second Quarter 2008 Financial Results

Highlights: * Received approvable letter for New Drug Application (NDA) for EUR-1008 (Zentase(r)) * Achieved successful FDA pre-approval inspection of Milan manufacturing facility...
August 06, 2008 08:55 ET | Source: Eurand N.V.

Eurand to Receive $35 Million Payment in Litigation Settlement

DAYTON, Ohio, Aug. 6, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) today announced that Eurand Inc. and UCB, Inc. have settled long-running litigation concerning a 1999 development, license and...
August 01, 2008 09:45 ET | Source: Eurand N.V.

Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd (South Korea) for Once-Daily Extended Release Muscle Relaxant

PHILADELPHIA, Pa., Aug. 1, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
July 18, 2008 08:00 ET | Source: Eurand N.V.

Eurand Announces Conference Call On Second Quarter 2008 Financial Results

AMSTERDAM, The Netherlands, July 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
July 16, 2008 16:11 ET | Source: Eurand N.V.

Eurand Industrial Award Honors Achievement in Drug Delivery Research

MILAN, Italy, July 16, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) and the Controlled Release Society (CRS) announced today that the 2008 Eurand Industrial Award has been presented to...
July 10, 2008 08:00 ET | Source: Eurand N.V.

Eurand Names Bill Newbould Vice President, Investor Relations

PHILADELPHIA, July 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
June 18, 2008 16:05 ET | Source: Eurand N.V.

Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)

PHILADELPHIA, June 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
June 03, 2008 09:00 ET | Source: Eurand N.V.

Eurand to Be Issued U.S. Patent for Amrix(r)

DAYTON, Ohio, June 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
May 20, 2008 08:00 ET | Source: Eurand N.V.

Eurand to Present At UBS Global Specialty and Generic Pharmaceuticals Conference

AMSTERDAM, May 20, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical...
May 15, 2008 16:00 ET | Source: Eurand N.V.

Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008

AMSTERDAM, The Netherlands, May 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...